Southerncare New Beacon - Jasper 300 North Airport Road, Units 3 And 4, Jasper, AL, 35504 | |
(205) 387-9339 |
News Archive
A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.
The study involved 10,902 primary school children from three cities in China at different stages of modernisation (Hong Kong, Beijing and Guangzhou). Parents were asked about asthmatic symptoms and exposure to environmental factors.
Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.
Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.
Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.
› Verified 8 days ago
Name | Southerncare New Beacon - Jasper |
---|---|
Location | 300 North Airport Road, Units 3 And 4, Jasper, Alabama |
Hospice ID | 011506 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 630 |
News Archive
A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.
The study involved 10,902 primary school children from three cities in China at different stages of modernisation (Hong Kong, Beijing and Guangzhou). Parents were asked about asthmatic symptoms and exposure to environmental factors.
Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.
Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.
Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.5 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 96.2 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 91.5 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 98.9 | 97.3 |
Patients who got timely treatment for shortness of breath | 97.4 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 96.9 | 93.3 |
News Archive
A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.
The study involved 10,902 primary school children from three cities in China at different stages of modernisation (Hong Kong, Beijing and Guangzhou). Parents were asked about asthmatic symptoms and exposure to environmental factors.
Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.
Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.
Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.
› Verified 8 days ago
Home Health Aides | 22 |
Counselors | 6 |
Licensed Practical or Vocational Nurses | 3 |
Medical Social Workers | 7 |
Physicians | 11 |
Registered Nurses | 42 |
Other Personnel | 17.5 |
Total Employees | 108.5 |
---|
News Archive
A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.
The study involved 10,902 primary school children from three cities in China at different stages of modernisation (Hong Kong, Beijing and Guangzhou). Parents were asked about asthmatic symptoms and exposure to environmental factors.
Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.
Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.
Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.
› Verified 8 days ago
Others | 56 |
Total Volunteers | 56 |
---|
News Archive
A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.
The study involved 10,902 primary school children from three cities in China at different stages of modernisation (Hong Kong, Beijing and Guangzhou). Parents were asked about asthmatic symptoms and exposure to environmental factors.
Neurocrine Biosciences, Inc. announced today that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for its Vesicular Monoamine Transporter 2 inhibitor, NBI-98854, in tardive dyskinesia.
Scientists have generated hundreds of new leads in the fight against the H1N1 flu pandemic, according to two new studies published online December 17th in the journal Cell, a Cell Press publication.
Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.
› Verified 8 days ago
Southerncare New Beacon - Jasper Location: 300 North Airport Road, Units 3 And 4, Jasper, Alabama, 35504 Phone: (205) 387-9339 |
Alabama Hospice Care Of Jasper Location: 1458 Jones Dairy Road, Suite 200, Jasper, Alabama, 35501 Phone: (205) 387-9339 |
Southeast Hospice Network, Llc Location: 4330 Highway 78e, Suite 120-121, Jasper, Alabama, 35501 Phone: (205) 387-9339 |